ARCHIVES

NCI Boosts Funding For Cooperative Groups by $25 Million, Cuts Overall Accrual by 20 Percent, to 20,000 Patients

This article is from The Cancer Letter archive.

Vol. 37 No. 42 | November 11, 2011

Download PDF Visit The Full Archive

Related Articles

NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate

October 22, 1993

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

New NCAB Appointees Include Some Old Hands; Korn Renamed Chairman

May 13, 1988

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

Maryland’s Greenebaum Cancer Center Wins NCI Designation.

September 12, 2008